Zacks Research Forecasts Weaker Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Analysts at Zacks Research reduced their Q2 2025 EPS estimates for Henry Schein in a note issued to investors on Monday, May 26th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.16 per share for the quarter, down from their previous estimate of $1.19. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein's Q4 2025 earnings at $1.24 EPS, FY2025 earnings at $4.82 EPS, Q1 2026 earnings at $1.23 EPS, Q2 2026 earnings at $1.27 EPS, FY2026 earnings at $5.23 EPS and Q1 2027 earnings at $1.32 EPS.

Several other brokerages have also recently issued reports on HSIC. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Barrington Research reduced their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Piper Sandler cut their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Wells Fargo & Company cut their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Finally, Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $79.30.

Henry Schein Stock Performance

Shares of Henry Schein stock traded down $2.12 during trading on Wednesday, hitting $69.86. 3,123,095 shares of the company's stock were exchanged, compared to its average volume of 1,672,150. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business has a 50-day simple moving average of $67.65 and a 200-day simple moving average of $71.69. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49. The stock has a market capitalization of $8.50 billion, a price-to-earnings ratio of 28.75, a PEG ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the firm posted $1.10 earnings per share. The business's revenue for the quarter was down .1% compared to the same quarter last year.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors and hedge funds have recently bought and sold shares of HSIC. Palestra Capital Management LLC acquired a new position in Henry Schein during the fourth quarter worth about $182,988,000. Lyrical Asset Management LP acquired a new position in Henry Schein during the fourth quarter worth about $126,655,000. Norges Bank acquired a new position in Henry Schein during the fourth quarter worth about $103,301,000. Steadfast Capital Management LP boosted its holdings in Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock valued at $113,336,000 after purchasing an additional 1,175,408 shares during the last quarter. Finally, Hudson Bay Capital Management LP boosted its holdings in Henry Schein by 102.1% in the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock valued at $101,378,000 after purchasing an additional 740,007 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.